Dialysis Clinical Trial
Official title:
Efficacy and Safety of a Very Low Protein Diet in Postponing Dialysis in Elderly: a Prospective Randomized Multicenter Controlled Study
There are no solid data on the real advantage of an early start of dialysis, as suggested by
the DOQI guidelines. Uremic patients frequently have a poor nutritional status. However, we
cannot distinguish between the detrimental effect on nutrition of too low a residual renal
function or too long a period of low protein-diet, per se. However, it appears that a
very-low-protein diet (VLPD) supplemented with essential amino acids and keto-analogs of
amino acids, and with an adequate quantity of calories, can prevent hypoalbuminemia at the
start of dialysis and can slow the progression of chronic renal failure.
EDTA and USRDS data suggest that most patients starting dialysis nowadays are elderly, who
also have the highest incidence of morbidity and mortality. Moreover, hospitalization rate
becomes higher after the start of dialysis compared to the pre-dialysis period.
Can an aminoacid-supplemented VLPD, prolonged beyond the GFR limits suggested by DOQI, offer
elderly patients better survival and better quality of life than dialysis? The answer can
only come from a prospective, randomized trial, in elderly patients, starting at the GFR
values suggested by the NKF-DOQI for starting dialysis, comparing outcomes with a vegetarian
VLPD supplemented with a mixture of keto-analogs of amino acids and essential amino acids,
and with dialysis.
An adequate dose of dialysis is needed, in order to improve patient outcome, in both
peritoneal dialysis (PD) and extracorporeal dialysis (HD). The debate, however, has renewed
interest in when to start dialysis. The NKF-DOQI group suggested using the amount of solute
clearance for regular dialysis as a value for starting dialysis treatment, i.e. creatinine
clearance 9-14 ml/min.
Elderly patients on dialysis have a low survival rate.In fact, according to the lombard
Registry(a italian region), patients 70-75 years old survive 2.9/3.6 years (male/female)
after the start of dialysis, those 75-80 years old 2.7/2.7 years, and those 80-85 years old
2.4/1.4 years. This low survival is largely due to the combined effects of aging and
comorbidities, on which an early start of dialysis has no or very limited positive effects.
Moreover, the hemodialytic treatment might have more negative effects in the elderly:
intermittent hemodynamic stress, continuous fluctuation of electrolytes, metabolites,
acid-base equilibrium, and the bioincompatibility of the membrane. In PD patients, the
negative effects are also related to episodes of peritonitis and to daily loss of protein
and a higher frequency of malnutrition.
An early start of dialysis should improve survival and well-being, and reduce morbidity. But
a rapid decline of residual renal function (RRF) is observed after the start of dialysis.
Maintenance of RRF as long as possible is very important, because the kidneys do some things
a dialysis membrane cannot do: tubular and endocrine function, larger clearances of middle
molecules, some of them potentially toxic such as parathyroid hormone, granulocyte
inhibitory protein, and substances inducing anorexia.
In a prospective study on CAPD patients, for every increase of 1 ml/min of GFR, the relative
risk (RR) of death decreased 50%. In the CanUsa study, using the time-dependent Cox
multivariate analysis, a 5% reduction in RR of death was observed for each 5L/week of
residual renal GFR at baseline (7). These results suggest that, at least in elderly
patients, the fast decline of GFR observed after the start of dialysis could be another
cause of the low survival rate.
In our center, 42 elderly patients started a very-low-protein diet (VLPD: 0.3 g of
protein/kg body weight), supplemented with a mixture of keto acids and amino acids when
their creatinine clearance reached values usually considered as a parameter for starting
dialysis. The survival of this group of patients was compared with that of 71 patients
directly put onto dialysis with the same creatinine clearance at which we started the VLPD.
Subsequently, 24 patients in the diet group started dialysis when their mean GFR was 3.9
ml/min, i.e. lower than the 7 ml/min usually considered adequate in PD patients and much
lower than 9-14 ml/min suggested by the NKF-DOQI group.
In this retrospective, non-randomized study, survival was better in the patients treated
with diet than patients with dialysis. This seems to bear out that RRF does more than a
dialytic membrane and must be preserved as long as possible.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05031013 -
Trace Elements Concentration in Dialysis
|
||
Not yet recruiting |
NCT03090828 -
Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease
|
N/A | |
Completed |
NCT01685372 -
Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults
|
Phase 2 | |
Active, not recruiting |
NCT01394770 -
Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients
|
Phase 4 | |
Completed |
NCT00537979 -
Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis
|
Phase 4 | |
Completed |
NCT00506441 -
A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
|
Phase 3 | |
Completed |
NCT05415969 -
CKD-aP Among Adults on Dialysis in Switzerland
|
||
Recruiting |
NCT04024007 -
Determination of Citrate Clearance Used in Regional Anticoagulation of Continuous Venous Hemofiltration Circuits
|
||
Completed |
NCT03772171 -
Estimate for Dietary Intakes and Hemodialysis Patients
|
||
Recruiting |
NCT02586402 -
Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis
|
Phase 2 | |
Active, not recruiting |
NCT01693263 -
Outcome of BCF Access in Hemodialysis Patients
|
||
Completed |
NCT01421771 -
Blood Pressure in Dialysis Patients
|
N/A | |
Active, not recruiting |
NCT01065389 -
Resistance Training in Intradialysis Patients
|
Phase 2 | |
Completed |
NCT00544492 -
Study of Pain, Anxiety and Complications Related to Cannulation of Arteriovenous (AV) Fistula in Chronic Hemodialysis Patients
|
Phase 4 | |
Completed |
NCT03910426 -
Prognostic Determinants of Survival and Quality of Life in Prevalent End-stage Kidney Disease Patients
|
||
Completed |
NCT04667741 -
Post-dialysis Recovery Time and Affecting Factors Between Turkey and Portugal
|
||
Completed |
NCT04565522 -
Transmission of COVID-19 Virus Among Patients and Staff in Dialysis Centers
|
||
Completed |
NCT04655989 -
A Study to Demonstrate the Safety and Effectiveness of the NIKKISO DBB-EXA ES Hemodialysis Delivery System
|
N/A | |
Completed |
NCT05125848 -
Clinical Evaluation of the CM-1500 During Hemodialysis
|
N/A | |
Completed |
NCT04633915 -
Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.
|